Etomidate is associated with mortality and adrenal insufficiency in sepsis: A meta-analysis

Critical Care Medicine

Volumn 40, Issue 11, 2012, Pages 2945-2953

  Chan, Chee Man ^a   Mitchell, Anthony L ^b   Shorr, Andrew F ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

adrenal insufficiency; etomidate; meta analysis; mortality; sepsis; septic shock

Indexed keywords

ETOMIDATE; KETAMINE; MIDAZOLAM; SEDATIVE AGENT; TETRACOSACTIDE;

ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; ARTIFICIAL VENTILATION; FOLLOW UP; HUMAN; META ANALYSIS; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SEPSIS; SEPTIC SHOCK; SIDE EFFECT; SINGLE DRUG DOSE; SYSTEMATIC REVIEW;

ADRENAL INSUFFICIENCY; AGED; AGED, 80 AND OVER; ANESTHETICS, INTRAVENOUS; ETOMIDATE; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS;

EID: 84868213623     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31825fec26     Document Type: Review

References (29)

1. Miranda DR, Stoutenbeek CP: Etomidate in the intensive care unit. Lancet 1983; 2:684-685
2. Ledingham IM, Watt I: Influence of sedation on mortality in critically ill multiple trauma patients. Lancet 1983; 1:1270
3. Murray H, Marik PE: Etomidate for endotracheal intubation in sepsis: Acknowledging the good while accepting the bad. Chest 2005; 127:707-709
4. Hildreth AN, Mejia VA, Maxwell RA, et al: Adrenal suppression following a single dose of etomidate for rapid sequence induction: A prospective randomized study. J Trauma 2008; 65:573-579
5. Jabre P, Combes X, Lapostolle F, et al; KETASED Collaborative Study Group: Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: A multicentre randomised controlled trial. Lancet 2009; 374:293-300
6. Sprung CL, Annane D, Keh D, et al; CORTICUS Study Group: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124
7. Ray DC, McKeown DW: Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock. Crit Care 2007; 11:R56
8. de Jong MF, Beishuizen A, Spijkstra JJ, et al: Predicting a low cortisol response to adrenocorticotrophic hormone in the critically ill: A retrospective cohort study. Crit Care 2007; 11:R61
9. Crowther MA, Cook DJ: Trials and tribulations of systematic reviews and meta-analyses. Hematology Am Soc Hematol Educ Program 2007:493-497
10. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17:1-12
11. Galbraith RF: A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988; 7:889-894
12. Huedo-Medina TB, Schez-Meca J, Mar-Martez F, et al: Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006; 11:193-206
13. Begg CB, Berlin JA: Publication bias and dissemination of clinical research. J Natl Cancer Inst 1989; 81:107-115
14. Cuthbertson BH, Sprung CL, Annane D, et al: The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 2009; 35:1868-1876
15. Dmello D, Taylor S, O'Brien J, et al: Outcomes of etomidate in severe sepsis and septic shock. Chest 2010; 138:1327-1332
16. Tekwani KL, Watts HF, Sweis RT, et al: A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: A prospective, randomized study. Ann Emerg Med 2010; 56:481-489
17. Tekwani KL, Watts HF, Rzechula KH, et al: A prospective observational study of the effect of etomidate on septic patient mortality and length of stay. Acad Emerg Med 2009; 16:11-14
18. Kim TY, Rhee JE, Kim KS, et al: Etomidate should be used carefully for emergent endotracheal intubation in patients with septic shock. J Korean Med Sci 2008; 23:988-991
19. Mohammad Z, Afessa B, Finkielman JD: The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate. Crit Care 2006; 10:R105
20. Annane D, Sille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
21. Rich?FC, Boutron CM, Valleur P, et al: Adrenal response in patients with septic shock of abdominal origin: Relationship to survival. Intensive Care Med 2007; 33: 1761-1766
22. Cherfan AJ, Tamim HM, AlJumah A, et al: Etomidate and mortality in cirrhotic patients with septic shock. BMC Clin Pharmacol 2011; 11:22
23. Albert SG, Ariyan S, Rather A: The effect of etomidate on adrenal function in critical illness: A systematic review. Intensive Care Med 2011; 37:901-910
24. Seitz W, Fritz K, L?be N, et al: [Suppression of the adrenal cortex by infusion of etomidate in general anesthesia]. Anasth Intensivther Notfallmed 1985; 20:125-130
25. Watt I, Ledingham IM: Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia 1984; 39:973-981
26. Hamrahian AH, Oseni TS, Arafah BM: Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004; 350:1629-1638
27. Payen JF, Dupuis C, Trouve-Buisson T, et al: Corticosteroid after etomidate in critically ill patients: A randomized controlled trial. Crit Care Med 2012; 40:29-35
28. Pejo E, Feng Y, Chao W, et al: Differential effects of etomidate and its pyrrole analogue carboetomidate on the adrenocortical and cytokine responses to endotoxemia. Crit Care Med 2012; 40:187-192
29. Higgins JP, Thompson SG, Deeks JJ, et al: Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560